Carta científico-clínica
Exantema intertriginoso y flexural simétrico por fármacos inducido por la vacuna COVID-19 Comirnaty (Pfizer/BioNTech)
Symmetrical Drug-Related Intertriginous Flexural Exanthema Induced by the Pfizer/BioNTech Comirnaty COVID-19 Vaccine
N.M. Román Mendoza
, L. Luna Bastante, A. Sánchez Gilo, F.J. Vicente Martin
Corresponding author
Servicio de Dermatología y Venereología, Hospital Universitario Rey Juan Carlos, Móstoles, Madrid, España
Read
10604
Timeswas read the article
1372
Total PDF
9232
Total HTML
Share statistics
array:24 [ "pii" => "S0001731023004209" "issn" => "00017310" "doi" => "10.1016/j.ad.2023.05.019" "estado" => "S300" "fechaPublicacion" => "2024-01-01" "aid" => "3517" "copyright" => "AEDV" "copyrightAnyo" => "2023" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2024;115:94-6" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "itemSiguiente" => array:18 [ "pii" => "S0001731023008621" "issn" => "00017310" "doi" => "10.1016/j.ad.2023.10.029" "estado" => "S300" "fechaPublicacion" => "2024-01-01" "aid" => "3721" "copyright" => "AEDV" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2024;115:T94-T96" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Case and Research Letters</span>" "titulo" => " Symmetrical Drug-Related Intertriginous Flexural Exanthema Induced by the Pfizer/BioNTech Comirnaty COVID-19 Vaccine" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "T94" "paginaFinal" => "T96" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Exantema intertriginoso y flexural simétrico por fármacos inducido por la vacuna COVID-19 Comirnaty (Pfizer/BioNTech)" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 316 "Ancho" => 756 "Tamanyo" => 47320 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">A,<span class="elsevierStyleHsp" style=""></span>Mainly lymphocytic superficial perivascular inflammatory infiltrate with occasional eosinophils (circle). B,<span class="elsevierStyleHsp" style=""></span>Bilateral inguinal erythema with well-defined borders and no fissuring.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "N.M. Román Mendoza, L. Luna Bastante, A. Sánchez Gilo, F.J. Vicente Martin" "autores" => array:4 [ 0 => array:2 [ "nombre" => "N.M." "apellidos" => "Román Mendoza" ] 1 => array:2 [ "nombre" => "L." "apellidos" => "Luna Bastante" ] 2 => array:2 [ "nombre" => "A." "apellidos" => "Sánchez Gilo" ] 3 => array:2 [ "nombre" => "F.J." "apellidos" => "Vicente Martin" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731023008621?idApp=UINPBA000044" "url" => "/00017310/0000011500000001/v1_202401030514/S0001731023008621/v1_202401030514/en/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S000173102300861X" "issn" => "00017310" "doi" => "10.1016/j.ad.2023.10.028" "estado" => "S300" "fechaPublicacion" => "2024-01-01" "aid" => "3720" "copyright" => "AEDV" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2024;115:T91-T93" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Scientific-Clinical Letter</span>" "titulo" => " In Vivo Laser Speckle Contrast Imaging to Measure Spider Crab Flap Perfusion" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "T91" "paginaFinal" => "T93" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Estudio <span class="elsevierStyleItalic">in vivo</span> del flujo vascular del colgajo centollo mediante láser de contraste de imagen por puntos" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0015" "etiqueta" => "Figure 3" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr3.jpeg" "Alto" => 927 "Ancho" => 1689 "Tamanyo" => 319058 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Direct correlation between the perfusion image and the tension vectors. The image on the left represents blood flow. Red indicates maximum perfusion. As blood flow diminishes, the color scale gradually degrades until it reaches blue-black, which indicates minimum perfusion. The image on the right shows the tension vectors at each suture point, such that the length of the arrows represents the magnitude of the tensions. The central vector highlighted with 3 red arrows is the point of maximum tension and, in the flow image on the left, corresponds exactly to the central area of minimum vascular flow shown in blue-black. The silhouette of the W-plasty scar, where the tensions are focused, corresponds exactly to the image of the blue flows.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "F. Russo-de la Torre, R. Vieira, M.E. Iglesias-Zamora" "autores" => array:3 [ 0 => array:2 [ "nombre" => "F." "apellidos" => "Russo-de la Torre" ] 1 => array:2 [ "nombre" => "R." "apellidos" => "Vieira" ] 2 => array:2 [ "nombre" => "M.E." "apellidos" => "Iglesias-Zamora" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S000173102300861X?idApp=UINPBA000044" "url" => "/00017310/0000011500000001/v1_202401030514/S000173102300861X/v1_202401030514/en/main.assets" ] "asociados" => array:1 [ 0 => array:18 [ "pii" => "S0001731023008621" "issn" => "00017310" "doi" => "10.1016/j.ad.2023.10.029" "estado" => "S300" "fechaPublicacion" => "2024-01-01" "aid" => "3721" "copyright" => "AEDV" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2024;115:T94-T96" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Case and Research Letters</span>" "titulo" => " Symmetrical Drug-Related Intertriginous Flexural Exanthema Induced by the Pfizer/BioNTech Comirnaty COVID-19 Vaccine" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "T94" "paginaFinal" => "T96" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Exantema intertriginoso y flexural simétrico por fármacos inducido por la vacuna COVID-19 Comirnaty (Pfizer/BioNTech)" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 316 "Ancho" => 756 "Tamanyo" => 47320 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">A,<span class="elsevierStyleHsp" style=""></span>Mainly lymphocytic superficial perivascular inflammatory infiltrate with occasional eosinophils (circle). B,<span class="elsevierStyleHsp" style=""></span>Bilateral inguinal erythema with well-defined borders and no fissuring.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "N.M. Román Mendoza, L. Luna Bastante, A. Sánchez Gilo, F.J. Vicente Martin" "autores" => array:4 [ 0 => array:2 [ "nombre" => "N.M." "apellidos" => "Román Mendoza" ] 1 => array:2 [ "nombre" => "L." "apellidos" => "Luna Bastante" ] 2 => array:2 [ "nombre" => "A." "apellidos" => "Sánchez Gilo" ] 3 => array:2 [ "nombre" => "F.J." "apellidos" => "Vicente Martin" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731023008621?idApp=UINPBA000044" "url" => "/00017310/0000011500000001/v1_202401030514/S0001731023008621/v1_202401030514/en/main.assets" ] ] "es" => array:15 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Carta científico-clínica</span>" "titulo" => "Exantema intertriginoso y flexural simétrico por fármacos inducido por la vacuna COVID-19 Comirnaty (Pfizer/BioNTech)" "tieneTextoCompleto" => true "saludo" => "<span class="elsevierStyleItalic">Sr. Director,</span>" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "94" "paginaFinal" => "96" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "N.M. Román Mendoza, L. Luna Bastante, A. Sánchez Gilo, F.J. Vicente Martin" "autores" => array:4 [ 0 => array:4 [ "nombre" => "N.M." "apellidos" => "Román Mendoza" "email" => array:1 [ 0 => "nellyromanmendoza@gmail.com" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:2 [ "nombre" => "L." "apellidos" => "Luna Bastante" ] 2 => array:2 [ "nombre" => "A." "apellidos" => "Sánchez Gilo" ] 3 => array:2 [ "nombre" => "F.J." "apellidos" => "Vicente Martin" ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Servicio de Dermatología y Venereología, Hospital Universitario Rey Juan Carlos, Móstoles, Madrid, España" "identificador" => "aff1" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Autor para correspondencia." ] ] ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Symmetrical Drug-Related Intertriginous Flexural Exanthema Induced by the Pfizer/BioNTech Comirnaty COVID-19 Vaccine" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 420 "Ancho" => 1007 "Tamanyo" => 72687 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">A)<span class="elsevierStyleHsp" style=""></span>Infiltrado inflamatorio perivascular superficial de predominio linfocítico con algún eosinófilo (círculo). B)<span class="elsevierStyleHsp" style=""></span>Eritema inguinal bilateral, bordes bien definidos, no fisuración.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Un hombre de 82<span class="elsevierStyleHsp" style=""></span>años, con antecedentes de dislipemia, diabetes mellitus y cardiopatía isquémica crónica, presentaba un exantema macular rosado, no descamativo, pruriginoso, sin despegamiento epidérmico, de varias semanas de evolución, de inicio en las ingles y con una extensión posterior a los flancos y la espalda. El paciente había cambiado de marca comercial de esomeprazol hacía un mes. Ante la sospecha de una toxicodermia, se retiró el esomeprazol y se trató tópicamente con crema de metilprednisolona aceponato 1<span class="elsevierStyleHsp" style=""></span>mg/g, con una resolución de las lesiones en una semana. En la analítica destacaba una eosinofilia leve y en la biopsia cutánea se observó un infiltrado inflamatorio perivascular superficial de predominio linfocítico con un edema leve, una discreta ectasia vascular y ocasionales eosinófilos (<a class="elsevierStyleCrossRef" href="#fig0005">fig. 1</a>A). Se realizó prick test con ambas marcas de esomeprazol y una prueba de provocación, con resultados negativos. Tras reiniciar su tratamiento con esomeprazol, no presentó una reaparición de las lesiones.</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0010" class="elsevierStylePara elsevierViewall">A los 5 meses consultó nuevamente por una recidiva de las lesiones (<a class="elsevierStyleCrossRef" href="#fig0005">fig. 1</a>B). Destacaba la administración de la tercera dosis de la vacuna COVID-19 (VC19) Comirnaty 48 horas antes del inicio de los síntomas. Reinterrogando al paciente, el episodio previo se había desarrollado a las 72<span class="elsevierStyleHsp" style=""></span>horas de haber recibido la segunda dosis de la misma vacuna.</p><p id="par0015" class="elsevierStylePara elsevierViewall">Ante la sospecha de un exantema intertriginoso y flexural simétrico por fármacos (<span class="elsevierStyleItalic">symmetric drug-related intetriginous and flexural exantema</span> [SDRIFE]), asociado a la administración de Comirnaty, se completó el prick test con la vacuna Comirnaty y con polietilenglicol (PEG) y se realizaron pruebas epicutáneas (PE) con batería estándar del GEIDAC, metales, metales especiales de Martí Tor®, cosméticos, acrilatos y PEG, siendo todos los resultados negativos. No se realizó prueba de provocación con la vacuna dada la reciente administración de la tercera dosis. Recibió tratamiento tópico con una crema de clobetasol 0,5<span class="elsevierStyleHsp" style=""></span>mg/g, con una resolución de las lesiones a las 4<span class="elsevierStyleHsp" style=""></span>semanas.</p><p id="par0020" class="elsevierStylePara elsevierViewall">Basándonos en las características clínicas y anatomopatológicas de las lesiones, la relación temporal con la administración de la vacuna, la ausencia de otras causas que pudieran justificar el cuadro y teniendo en cuenta los criterios de causalidad de Naranjo<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">1</span></a>, el paciente fue diagnosticado de un «probable» SDRIFE inducido por la vacuna Comirnaty.</p><p id="par0025" class="elsevierStylePara elsevierViewall">El SDRIFE, antes conocido como síndrome de Baboon, es una forma de dermatitis de contacto sistémica. Se manifiesta como un exantema eritematoso, simétrico, localizado preferentemente en las nalgas, en los genitales y en las zonas de flexión de las extremidades. Ocurre cuando un individuo está sensibilizado a un alérgeno de contacto al que se expone por vía sistémica (transcutánea, transmucosa, intravenosa, intramuscular, oral, inhalatoria). Es una entidad benigna, sin manifestaciones de toxicidad sistémica, con buen pronóstico tras la retirada del agente causal<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">2</span></a>.</p><p id="par0030" class="elsevierStylePara elsevierViewall">Se han publicado 10 casos de SDRIFE en relación con la VC19, cinco casos por Comirnaty<a class="elsevierStyleCrossRefs" href="#bib0065"><span class="elsevierStyleSup">3-6</span></a>, dos por CoronaVac<a class="elsevierStyleCrossRefs" href="#bib0080"><span class="elsevierStyleSup">6,7</span></a> y tres por Vaxzevria/ChAdOx1 nCoV-19 (AstraZeneca-Oxford)<a class="elsevierStyleCrossRefs" href="#bib0090"><span class="elsevierStyleSup">8-10</span></a> (<a class="elsevierStyleCrossRef" href="#tbl0005">tabla 1</a>). Los síntomas pueden presentarse desde las primeras horas de la exposición hasta varias semanas después<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">2</span></a>. En siete pacientes el exantema se manifestó tras la segunda dosis de la vacuna. En todos los casos los síntomas y signos de afectación sistémica estuvieron ausentes.</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0035" class="elsevierStylePara elsevierViewall">Los hallazgos histopatológicos del SDRIFE son inespecíficos<a class="elsevierStyleCrossRefs" href="#bib0065"><span class="elsevierStyleSup">3,4,7</span></a>. Podemos encontrar infiltrados linfohistiocitarios perivasculares superficiales que pueden incluir neutrófilos o eosinófilos<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">2</span></a>. La espongiosis puede o no estar presente.</p><p id="par0040" class="elsevierStylePara elsevierViewall">Previamente se han descrito casos de SDRIFE asociados a vacunas que contenían tiomersal entre sus componentes. Este componente no forma parte de las VC19 descritas. El adyuvante de la vacuna Comirnaty estudiado como posible responsable es el PEG.</p><p id="par0045" class="elsevierStylePara elsevierViewall">En los casos descritos por la VC19 se realizaron PE en cuatro pacientes<a class="elsevierStyleCrossRefs" href="#bib0065"><span class="elsevierStyleSup">3,6,10</span></a>, con un resultado positivo para el níquel en uno de ellos<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">3</span></a>. El prick test se realizó en tres pacientes, con un resultado negativo<a class="elsevierStyleCrossRefs" href="#bib0080"><span class="elsevierStyleSup">6,10</span></a>. Las PE y el prick test pueden dar resultados negativos. Esto podría deberse a la menor absorción de los fármacos por vía sistémica cuando son aplicados a través de la piel. El test intradérmico con la vacuna fue positivo en un caso; sin embargo, esta respuesta puede ser positiva, como una respuesta inmune local en pacientes que han recibido previamente la vacuna<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">6</span></a>. Las pruebas de provocación suelen ser positivas en la mayoría de los casos de SDRIFE<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">2</span></a>. No se han descrito pruebas de provocación con las VC19. Todos presentaron una buena respuesta a los corticoides tópicos u orales, con resolución de las lesiones cutáneas a las pocas semanas.</p><p id="par0050" class="elsevierStylePara elsevierViewall">Tras iniciar la vacunación frente a la COVID-19 a nivel mundial se están describiendo casos de SDRIFE secundarios a estas vacunas. Aportamos el caso de un paciente que desarrolla un SDRIFE tras la segunda y tercera dosis de la vacuna Comirnaty.</p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Conflicto de intereses</span><p id="par0055" class="elsevierStylePara elsevierViewall">Los autores declaran no tener ningún conflicto de intereses.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:2 [ 0 => array:2 [ "identificador" => "sec0005" "titulo" => "Conflicto de intereses" ] 1 => array:1 [ "titulo" => "Bibliografía" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "multimedia" => array:2 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 420 "Ancho" => 1007 "Tamanyo" => 72687 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">A)<span class="elsevierStyleHsp" style=""></span>Infiltrado inflamatorio perivascular superficial de predominio linfocítico con algún eosinófilo (círculo). B)<span class="elsevierStyleHsp" style=""></span>Eritema inguinal bilateral, bordes bien definidos, no fisuración.</p>" ] ] 1 => array:8 [ "identificador" => "tbl0005" "etiqueta" => "Tabla 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at1" "detalle" => "Tabla " "rol" => "short" ] ] "tabla" => array:2 [ "leyenda" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">H: hombre; M: mujer.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Vacuna \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Edad (años) \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Sexo \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Dosis \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Inicio \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Analítica \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Biopsia \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Pruebas cutáneas \t\t\t\t\t\t\n \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Comirnaty<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">3</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">23 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">H \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2.<span class="elsevierStyleSup">a</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">6 semanas \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Eosinofilia \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Dermatitis vacuolar de interfase. Leve espongiosisIFD negativa \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">No \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Comirnaty<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">3</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">38 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">M \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2.<span class="elsevierStyleSup">a</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2 semanas \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Normal \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Espongiosis con eosinófilos.IFD negativa \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">SíNíquel leve + \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Comirnaty<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">4</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">59 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">H \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">3.<span class="elsevierStyleSup">a</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2 días \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Leucocitosis. Neutrofilia \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Infiltrado linfocitario perivascular superficial con eosinófilos \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">No \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Comirnaty<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">5</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">65 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">H \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">¿? \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2 semanas \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">¿? \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">¿? \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">¿? \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Comirnaty<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">6</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">52 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">M \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2.<span class="elsevierStyleSup">a</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">5 días \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Normal \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">No \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Epicutáneas/Prick test negativas.Intradérmicas positivas \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">CoronaVac<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">6</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">57 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">M \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2.<span class="elsevierStyleSup">a</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">3 días \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Normal \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">No \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Epicutáneas/Prick test/intradérmica negativas \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">CoronaVac<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">7</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">87 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">H \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">¿? \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">4 días \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Elevación parámetros perfil renal \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Hiperqueratosis, acantosis, espongiosis, infiltración perivascular linfohistiocitaria, extravasación eritrocitaria \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">No \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Vaxzevria<a class="elsevierStyleCrossRef" href="#bib0090"><span class="elsevierStyleSup">8</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">61 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">H \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2.<span class="elsevierStyleSup">a</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1 día \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Leve leucocitosis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">No \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">No \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Vaxzevria<a class="elsevierStyleCrossRef" href="#bib0095"><span class="elsevierStyleSup">9</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">53 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">H \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2.<span class="elsevierStyleSup">a</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">10 días \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Normal \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">No \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">No \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Vaxzevria<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">10</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">67 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">M \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2.<span class="elsevierStyleSup">a</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">5 días \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Normal \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">No \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Prick/intradérmico test negativos \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab3424661.png" ] ] ] ] "descripcion" => array:1 [ "es" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">SDRIFE descritos por vacunas COVID-19</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "Bibliografía" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:10 [ 0 => array:3 [ "identificador" => "bib0055" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A method for estimating the probability of adverse drug reactions" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C.A. Naranjo" 1 => "U. Busto" 2 => "E.M. Sellers" 3 => "P. Sandor" 4 => "I. Ruiz" 5 => "E.A. Roberts" ] ] ] ] ] "host" => array:2 [ 0 => array:2 [ "doi" => "10.1038/clpt.1981.154" "Revista" => array:6 [ "tituloSerie" => "Clin Pharmacol Ther." "fecha" => "1981" "volumen" => "30" "paginaInicial" => "239" "paginaFinal" => "245" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/7249508" "web" => "Medline" ] ] ] ] 1 => array:2 [ "doi" => "10.1038/clpt.1981.154" "WWW" => array:1 [ "link" => "https://doi.org/10.1038/clpt.1981.154" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0060" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The baboon syndrome: Systemically-induced allergic contact dermatitis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "K.E. Andersen" 1 => "N. Hjorth" 2 => "T. Menné" ] ] ] ] ] "host" => array:2 [ 0 => array:2 [ "doi" => "10.1111/j.1600-0536.1984.tb00343.x" "Revista" => array:6 [ "tituloSerie" => "Contact Dermatitis." "fecha" => "1984" "volumen" => "10" "paginaInicial" => "97" "paginaFinal" => "100" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/6232098" "web" => "Medline" ] ] ] ] 1 => array:2 [ "doi" => "10.1111/j.1600-0536.1984.tb00343.x" "WWW" => array:1 [ "link" => "https://doi.org/10.1111/j.1600-0536.1984.tb00343.x" ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0065" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Systemic drug-related intertriginous and flexural exanthema induced by the Pfizer-BioNTech COVID-19 vaccine: A report of 2 cases" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J. Hai" 1 => "H. Shawa" 2 => "P. Kim-Lim" 3 => "J.Z. Wang" 4 => "M. Vy" 5 => "M.A. Fung" ] ] ] ] ] "host" => array:2 [ 0 => array:2 [ "doi" => "10.1016/j.jdcr.2021.10.016" "Revista" => array:6 [ "tituloSerie" => "JAAD Case Rep." "fecha" => "2021" "volumen" => "18" "paginaInicial" => "57" "paginaFinal" => "60" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34722840" "web" => "Medline" ] ] ] ] 1 => array:2 [ "doi" => "10.1016/j.jdcr.2021.10.016" "WWW" => array:1 [ "link" => "https://doi.org/10.1016/j.jdcr.2021.10.016" ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0070" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A case of symmetrical drug-related intertriginous and flexural exanthema-like eruption associated with Pfizer COVID-19 vaccination" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "A. Manaa" 1 => "M. Ziv" 2 => "J. Krausz" 3 => "R.P. Dodiuk-Gad" ] ] ] ] ] "host" => array:2 [ 0 => array:2 [ "doi" => "10.1111/dth.15546" "Revista" => array:5 [ "tituloSerie" => "Dermatol Ther." "fecha" => "2022" "volumen" => "35" "paginaInicial" => "e15546" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/35485220" "web" => "Medline" ] ] ] ] 1 => array:2 [ "doi" => "10.1111/dth.15546" "WWW" => array:1 [ "link" => "https://doi.org/10.1111/dth.15546" ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0075" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cutaneous adverse reactions associated with SARS-CoV-2 vaccines" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "F. Bellinato" 1 => "M. Maurelli" 2 => "P. Gisondi" 3 => "G. Girolomoni" ] ] ] ] ] "host" => array:2 [ 0 => array:2 [ "doi" => "10.3390/jcm10225344" "Revista" => array:5 [ "tituloSerie" => "J Clin Med." "fecha" => "2021" "volumen" => "10" "paginaInicial" => "5344" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34830627" "web" => "Medline" ] ] ] ] 1 => array:2 [ "doi" => "10.3390/jcm10225344" "WWW" => array:1 [ "link" => "https://doi.org/10.3390/jcm10225344" ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0080" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Symmetrical drug-related intertriginous and flexural exanthema-like eruption after COVID-19 vaccine" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "I. Lahouel" 1 => "N. Ben Salah" 2 => "N. Ben Fadhel" 3 => "F. Chahed" 4 => "N. Ouni" 5 => "H. Belhadjali" ] ] ] ] ] "host" => array:2 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Eur Acad Dermatol Venereol." "fecha" => "2022" "volumen" => "36" "paginaInicial" => "e597" "paginaFinal" => "e599" ] ] 1 => array:1 [ "WWW" => array:1 [ "link" => "https://doi.org/10.1111/jdv.18108" ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0085" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Systemic drug-related intertriginous and flexural exanthema like eruption after CoronaVac vaccine" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "O.M. Orenay" 1 => "I. Balta" 2 => "D. Yigit" 3 => "M. Eksioglu" ] ] ] ] ] "host" => array:2 [ 0 => array:2 [ "doi" => "10.1111/jdv.17454" "Revista" => array:6 [ "tituloSerie" => "J Eur Acad Dermatol Venereol." "fecha" => "2021" "volumen" => "35" "paginaInicial" => "e634" "paginaFinal" => "e635" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34138472" "web" => "Medline" ] ] ] ] 1 => array:2 [ "doi" => "10.1111/jdv.17454" "WWW" => array:1 [ "link" => "https://doi.org/10.1111/jdv.17454" ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0090" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Symmetrical drug-related intertriginous and flexural exanthema like eruption associated with COVID-19 vaccination" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "P.N. Lim" 1 => "G. Wylie" ] ] ] ] ] "host" => array:2 [ 0 => array:2 [ "doi" => "10.1111/ced.14898" "Revista" => array:6 [ "tituloSerie" => "Clin Exp Dermatol." "fecha" => "2022" "volumen" => "47" "paginaInicial" => "175" "paginaFinal" => "176" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34399001" "web" => "Medline" ] ] ] ] 1 => array:2 [ "doi" => "10.1111/ced.14898" "WWW" => array:1 [ "link" => "https://doi.org/10.1111/ced.14898" ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0095" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Symmetric drug-related intertriginous and flexural exanthema-like eruption related to coronavirus disease 2019 vaccine" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "J.K. Hong" 1 => "S.H. Shin" 2 => "K.H. Yoo" 3 => "K. Li" 4 => "S.J. Seo" ] ] ] ] ] "host" => array:2 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Contact Dermatitis." "fecha" => "2022" "volumen" => "87" "paginaInicial" => "91" "paginaFinal" => "93" ] ] 1 => array:1 [ "WWW" => array:1 [ "link" => "https://doi.org/10.1111/cod.14092" ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0100" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Systemic drug-related intertriginous and flexural exanthema-like eruption after Oxford-AstraZeneca COVID-19 vaccine" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "D. Di Bona" 1 => "A. Miniello" 2 => "E. Nettis" ] ] ] ] ] "host" => array:2 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "Clin Mol Allergy." "fecha" => "2022" "volumen" => "20" "paginaInicial" => "13" ] ] 1 => array:1 [ "WWW" => array:1 [ "link" => "https://doi.org/10.1186/s12948-022-00179-8" ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "es" "url" => "/00017310/0000011500000001/v1_202401030514/S0001731023004209/v1_202401030514/es/main.assets" "Apartado" => array:4 [ "identificador" => "6160" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Cartas científico-clínicas" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/00017310/0000011500000001/v1_202401030514/S0001731023004209/v1_202401030514/es/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731023004209?idApp=UINPBA000044" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 95 | 12 | 107 |
| 2024 October | 672 | 84 | 756 |
| 2024 September | 508 | 66 | 574 |
| 2024 August | 530 | 90 | 620 |
| 2024 July | 634 | 63 | 697 |
| 2024 June | 565 | 60 | 625 |
| 2024 May | 631 | 71 | 702 |
| 2024 April | 537 | 87 | 624 |
| 2024 March | 612 | 98 | 710 |
| 2024 February | 916 | 74 | 990 |
| 2024 January | 1790 | 149 | 1939 |
| 2023 December | 308 | 108 | 416 |
| 2023 November | 695 | 67 | 762 |
| 2023 October | 154 | 69 | 223 |
| 2023 September | 152 | 58 | 210 |
| 2023 August | 131 | 48 | 179 |
| 2023 July | 204 | 93 | 297 |
| 2023 June | 98 | 75 | 173 |
Show all
